Andere Sprachen Island Pharmaceuticals Limited

Aktien

A2QSJR

AU0000138869

ILA

Markt geschlossen - Australian S.E. Andere Börsenplätze 05:57:32 22.05.2024			% 5 Tage	% 1. Jan.
0,069 ^AUD	-1,43 %		+9,52 %	-27,37 %

08.05.	Island Pharmaceuticals weist Zuschussmittel für Dengue-Fieber-Studie um; Aktien steigen um 13%	MT
25.02.	Island Pharmaceuticals Limited meldet Ergebnis für das am 31. Dezember 2023 endende Halbjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13%	08.05.
Island Pharmaceuticals Reports Positive Data from Dose Study of Dengue Medication	16.04.
Island Pharmaceuticals to raise $1.95 million for ISLA-101 development	27.02.
Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	25.02.
Australia Shares Fall as Central Bank Keeps Rates Steady	06.02.
Island Pharmaceuticals Achieves Primary Endpoint in Dengue Drug Ascending Dose Study	06.02.
Island Pharmaceuticals Doses Subjects with Third Cohort for Dengue Medication Study	19.01.
Island Pharmaceuticals' ISLA-101 Study Advances to Third Cohort Dosing	26.12.
Island Pharmaceuticals Signs R&D Loan Deal With Radium Capital	15.12.
Island Pharmaceuticals Announces Change of Company Secretaries	01.12.
Island Pharmaceuticals Administers First Drug Cohort for Dengue Medication Study	24.11.
Island Pharma one step closer to ISLA-101 dosing	22.11.
Island Pharmaceuticals Begins Screening for Dengue Medication Study	13.11.
Island Pharmaceuticals Gets Nearly AU$390,000 R&D Tax Rebate; Shares Fall 4%	10.11.
Island Pharma welcomes green light for ISLA-101 clinical study	07.11.
Island Pharmaceuticals Receives Ethics Approval for Ascending Dose Study	07.11.
Island Pharmaceuticals Secures Australian Patent for Flavivirus Treatment	02.11.
Island Pharma gearing up to start ISLA-101 trial for dengue fever	27.09.23
Island Pharmaceuticals to Start Dengue Drug Trial in October	26.09.23
Island Pharmaceuticals Secures US Patent to Support Dengue Medication	13.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Island Pharmaceuticals Limited

Aktien

A2QSJR

AU0000138869

ILA

Andere Sprachen

Filter